BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $12.1 million in its fourth quarter. The Burlingame, California-based ...

SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that Richard van den Broek ...

Corvus Pharmaceuticals' stock has experienced volatility due to mixed clinical data, particularly from their lead asset soquelitinib's Phase 1 trial in atopic dermatitis. The company has promising ...

Project Corvus is intended to provide the British Army with a new Land Tactical Deep Find capability to replace what was previously provided by the Watchkeeper UAS ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Corvus Pharmaceuticals highlighted significant progress for soquelitinib, including ongoing Phase 3 trials for T-cell lymphoma and advancements in atopic dermatitis studies. The company has ...

Crows served the gods and goddesses as reliable messengers on Mount Olympus with great distinction until Corvus, the bungling, dishonest crow, messed it up for all crows forever. That’s one of ...

Throughout the ages crows have been getting a bad rap. Along with being big, black, ugly, and considered stupid, their singing is anything but beautiful. I’m sure you’ve heard the old ...

Maritime Reporter E-News is the maritime industry's largest circulation and most authoritative ENews Service, delivered to your Email five times per week ...

At close: 17 April at 16:00:01 GMT-4 ...